Cargando…

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in BRCA1 or BRCA2 Mutation Families

According to clinical guidelines, the occurrence of very early-onset breast cancer (VEO-BC) (diagnosed ≤ age 30 years) or VEO ovarian cancer (VEO-OC) (diagnosed ≤ age 40 years) in families with BRCA1 or BRCA2 mutation (BRCAm) prompts advancing the age of risk-reducing strategies in relatives. This s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imbert-Bouteille, Marion, Corsini, Carole, Picot, Marie-Christine, Mizrahy, Lucas, Akouete, Sandrine, Huguet, Helena, Thomas, Frédéric, Geneviève, David, Taourel, Patrice, Ychou, Marc, Galibert, Virginie, Rideau, Chloé, Baudry, Karen, Kogut Kubiak, Tatiana, Coupier, Isabelle, Hobeika, Rémy, Macary, Yvette, Toledano, Alain, Solassol, Jérôme, Maalouf, Antoine, Daures, Jean-Pierre, Pujol, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305427/ https://www.ncbi.nlm.nih.gov/pubmed/34356116 http://dx.doi.org/10.3390/genes12071100

Ejemplares similares

Predominance of BRCA2 Mutation and Estrogen Receptor Positivity in Unselected Breast Cancer with BRCA1 or BRCA2 Mutation
por: Pujol, Pascal, et al.
Publicado: (2022)

Is BRCA2 involved in early onset colorectal cancer risk?
por: Gay‐Bellile, Mathilde, et al.
Publicado: (2019)

Mutational analysis of BRCA1 and BRCA2 genes in Spanish women with early-onset breast cancer
por: Martínez-Ferrandis, JI, et al.
Publicado: (2000)

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer
por: Yassaee, Vahid R, et al.
Publicado: (2002)

Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours
por: Królewska, Katarzyna, et al.
Publicado: (2004)

Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectives
por: Vande Perre, Pierre, et al.
Publicado: (2018)

BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia
por: Tamboom, Kristiina, et al.
Publicado: (2010)

Impact of BRCA1 mutation on survival after early onset breast cancer
por: Huzarski, T, et al.
Publicado: (2012)

The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan
por: Abdikhakimov, Abdulla, et al.
Publicado: (2016)

BRCA1/2 mutation spectrum in Chinese early-onset breast cancer
por: Shen, Mengjia, et al.
Publicado: (2019)

BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History
por: Toh, Gaik Theng, et al.
Publicado: (2008)

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations
por: Dite, G S, et al.
Publicado: (2010)

Contribution of BRCA1 and BRCA2 germline mutations to early onset breast cancer: a series from north of Morocco
por: Bakkach, Joaira, et al.
Publicado: (2020)

Prevalence of BRCA1 and BRCA2 Germline Mutations in Patients of African Descent with Early-Onset and Familial Colombian Breast Cancer
por: Vargas, Elizabeth, et al.
Publicado: (2022)

Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers
por: Evans, DG, et al.
Publicado: (2017)

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer
por: Agalliu, I, et al.
Publicado: (2007)

A common missense variant in BRCA2 predisposes to early onset breast cancer
por: Górski, Bohdan, et al.
Publicado: (2005)

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives
por: Sng, J-H, et al.
Publicado: (2000)

BRCA1 Mutation Analysis in a Portuguese Population with Early-Onset Breast and/or Ovarian Cancer
por: Soares, Raquel, et al.
Publicado: (1999)

Identification of a BRCA2 mutation in a Turkish family with early‐onset breast cancer
por: Celik, Elifnaz, et al.
Publicado: (2018)

Constitutional mosaicism for a BRCA2 mutation as a cause of early-onset breast cancer
por: Alhopuro, Pia, et al.
Publicado: (2020)

Insights Into the Impacts of BRCA Mutations on Clinicopathology and Management of Early-Onset Triple-Negative Breast Cancer
por: Ye, Fugui, et al.
Publicado: (2021)

Comprehensive Analysis of BRCA1, BRCA2 and TP53 Germline Mutation and Tumor Characterization: A Portrait of Early-Onset Breast Cancer in Brazil
por: Carraro, Dirce Maria, et al.
Publicado: (2013)

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
por: Loman, Niklas, et al.
Publicado: (2003)

Germline truncating-mutations in BRCA1 and MSH6 in a patient with early onset endometrial cancer
por: Kast, Karin, et al.
Publicado: (2012)

Mutation Screening of the BRCA1 Gene in Early Onset and Familial Breast/Ovarian Cancer in Moroccan Population
por: Laraqui, Abdelilah, et al.
Publicado: (2012)

Hereditary Susceptibility to Breast Cancer: Significance of Age of Onset in Family History and Contribution of BRCA1 and BRCA2
por: Frank, Thomas S., et al.
Publicado: (1999)

A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer
por: Kwong, Ava, et al.
Publicado: (2011)

A new case of “de novo” BRCA1 mutation in a patient with early‐onset breast cancer
por: Antonucci, Ivana, et al.
Publicado: (2017)

Constitutive BRCA1 Promoter Hypermethylation Can Be a Predisposing Event in Isolated Early-Onset Breast Cancer
por: Azzollini, Jacopo, et al.
Publicado: (2019)

Early-Onset Breast Cancer in a Family with Neurofibromatosis Type 1 Associated with a Germline Mutation in BRCA1
por: Jeon, Ye Won, et al.
Publicado: (2015)

Breast cancer in West Africa: molecular analysis of BRCA genes in early-onset breast cancer patients in Burkina Faso
por: Biancolella, Michela, et al.
Publicado: (2021)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
por: Hyder, Zerin, et al.
Publicado: (2020)

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
por: Henouda, Sarra, et al.
Publicado: (2016)

Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients
por: Lee, Daphne SC, et al.
Publicado: (2012)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancer and early-onset sporadic breast cancer
por: Hansmann, Tamara, et al.
Publicado: (2012)

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer
por: Maxwell, Kara N., et al.
Publicado: (2014)

Association of BRCA1 185 del AG with early age onset of breast cancer patients in selected cohort from Pakistani population
por: Durr-e-Samin,, et al.
Publicado: (2018)

MSH2 is the very young onset ovarian cancer predisposition gene, not BRCA1
por: Flaum, Nicola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_02vmnspl1k1v8c4fj44r45atqq